These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9528993)

  • 21. Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats.
    Prins GS; Marmer M; Woodham C; Chang W; Kuiper G; Gustafsson JA; Birch L
    Endocrinology; 1998 Mar; 139(3):874-83. PubMed ID: 9492016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoblastic differentiation induced by transcription factor decoy against estrogen receptor alpha gene.
    Lambertini E; Penolazzi L; Aguiari G; del Senno L; Pezzetti F; Sollazzo V; Piva R
    Biochem Biophys Res Commun; 2002 Apr; 292(3):761-70. PubMed ID: 11922631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures.
    Owen TA; Aronow MS; Barone LM; Bettencourt B; Stein GS; Lian JB
    Endocrinology; 1991 Mar; 128(3):1496-504. PubMed ID: 1999168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor isoform-specific induction of progesterone receptors in human osteoblasts.
    Rickard DJ; Waters KM; Ruesink TJ; Khosla S; Katzenellenbogen JA; Katzenellenbogen BS; Riggs BL; Spelsberg TC
    J Bone Miner Res; 2002 Apr; 17(4):580-92. PubMed ID: 11918216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in insulin-like growth factor-binding protein expression and secretion during the proliferation, differentiation, and mineralization of primary cultures of rat osteoblasts.
    Birnbaum RS; Wiren KM
    Endocrinology; 1994 Jul; 135(1):223-30. PubMed ID: 8013356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of estrogen receptors alfa and beta mRNA and alkaline phosphatase in the differentiation of osteoblasts from elderly postmenopausal women: comparison with osteoblasts from osteosarcoma cell lines.
    Chen FP; Hsu T; Hu CH; Wang WD; Wang KC; Teng LF
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):307-12. PubMed ID: 17175487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone matrix mRNA expression in differentiating fetal bovine osteoblasts.
    Ibaraki K; Termine JD; Whitson SW; Young MF
    J Bone Miner Res; 1992 Jul; 7(7):743-54. PubMed ID: 1642143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression.
    Ryoo HM; Hoffmann HM; Beumer T; Frenkel B; Towler DA; Stein GS; Stein JL; van Wijnen AJ; Lian JB
    Mol Endocrinol; 1997 Oct; 11(11):1681-94. PubMed ID: 9328350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures.
    Malaval L; Modrowski D; Gupta AK; Aubin JE
    J Cell Physiol; 1994 Mar; 158(3):555-72. PubMed ID: 8126078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis.
    Dang ZC; van Bezooijen RL; Karperien M; Papapoulos SE; Löwik CW
    J Bone Miner Res; 2002 Mar; 17(3):394-405. PubMed ID: 11878304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coordinate expression of novel genes during osteoblast differentiation.
    Seth A; Lee BK; Qi S; Vary CP
    J Bone Miner Res; 2000 Sep; 15(9):1683-96. PubMed ID: 10976989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of DNA replication inhibition on expression of cell growth and tissue-specific genes in osteoblasts and osteosarcoma cells.
    Kockx M; McCabe L; Stein JL; Lian JB; Stein GS
    J Cell Biochem; 1994 Jan; 54(1):47-55. PubMed ID: 8126086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line.
    Bodine PV; Green J; Harris HA; Bhat RA; Stein GS; Lian JB; Komm BS
    J Cell Biochem; 1997 Jun; 65(3):368-87. PubMed ID: 9138093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human bone marrow osteoprogenitors express estrogen receptor-alpha and bone morphogenetic proteins 2 and 4 mRNA during osteoblastic differentiation.
    Oreffo RO; Kusec V; Romberg S; Triffitt JT
    J Cell Biochem; 1999 Dec; 75(3):382-92. PubMed ID: 10536362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of differentiation and transforming growth factor beta 1 on PTH/PTHrP receptor mRNA levels in MC3T3-E1 cells.
    McCauley LK; Koh AJ; Beecher CA; Cui Y; Decker JD; Franceschi RT
    J Bone Miner Res; 1995 Aug; 10(8):1243-55. PubMed ID: 8585429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis.
    Bonnelye E; Kung V; Laplace C; Galson DL; Aubin JE
    Endocrinology; 2002 Sep; 143(9):3658-70. PubMed ID: 12193582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for heterogeneity of the osteoblastic phenotype determined with clonal rat bone cells established from transforming growth factor-beta-induced cell colonies grown anchorage independently in semisolid medium.
    Guenther HL; Hofstetter W; Stutzer A; Mühlbauer R; Fleisch H
    Endocrinology; 1989 Oct; 125(4):2092-102. PubMed ID: 2676479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss.
    Windahl SH; Hollberg K; Vidal O; Gustafsson JA; Ohlsson C; Andersson G
    J Bone Miner Res; 2001 Aug; 16(8):1388-98. PubMed ID: 11499861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron chelator deferoxamine alters iron-regulatory genes and proteins and suppresses osteoblast phenotype in fetal rat calvaria cells.
    Messer JG; Cooney PT; Kipp DE
    Bone; 2010 May; 46(5):1408-15. PubMed ID: 20102755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.